EVERYDAY SUPPORT FROM DAY ONE
LIVE

Serial Number

98093911

Owner

Day One Biopharmaceuticals, Inc.

Attorney

Maury M. Tepper, III

First Use Date

Apr 23, 2024

Filing Date

Jul 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EVERYDAY SUPPORT FROM DAY ONE Trademark

Serial Number: 98093911 • Registration: 8315462

EVERYDAY SUPPORT FROM DAY ONE is a trademark filed by Day One Biopharmaceuticals, Inc. on July 20, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Day One Biopharmaceuticals, Inc.

1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005

Entity Type: 03

Trademark Details

Filing Date

July 20, 2023

Registration Date

June 23, 2026

First Use Anywhere

April 23, 2024

First Use in Commerce

April 23, 2024

Published for Opposition

April 22, 2025

Goods & Services

Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, providing financial patient assistance by providing patients and their families with access to financial support through copay support, patient assistance programs (PAP), and referrals to independent patient foundations and organizations; financial services, namely, financial administration of patient reimbursement programs

healthcare services, namely, wellness and disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; ; providing information regarding the treatment and diagnosis of cancer; providing medical information relating to prescription drugs; Providing medication adherence support, namely, communicating with patients and caregivers regarding pharmaceutical drug weekly dosing requirements and impediments to taking pharmaceutical drugs as prescribed for medical treatment purposes

Educational services, namely, providing training regarding the treatment, and diagnosis of diseases; educational services, namely, providing prescription drug dosage training

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 31, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 31, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 5, 2026 SUPC
USE AMENDMENT FILED
Dec 16, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 16, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 17, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2025 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 10, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 10, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 10, 2025 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 31, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 1, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 1, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 1, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 30, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 31, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 1, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2023 NWOS
NEW APPLICATION ENTERED
Jul 24, 2023 NWAP